obicetrapib

NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test
Fierce Biotech
Mon, 07/29/24 - 10:27 am
NewAmsterdam Pharma
cholesterol
clinical trials
obicetrapib
HeFH
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
NewAmsterdam Pharma
Amgen
CETP inhibitors
obicetrapib
clinical trials
Thought CETP inhibition was dead? Think again
EP Vantage
Sat, 04/23/22 - 04:17 pm
New Amsterdam
Amgen
CETP inhibitors
obicetrapib
A new biotech forms to revive Amgen's old heart drug
BioPharma Dive
Thu, 08/27/20 - 10:57 am
Amgen
NewAmsterdam Pharma
obicetrapib
heart disease